Micro Pharmaceuticals
Market Cap
₹1,323 ₹1,323 Cr.
P/E
21.87
PEG = P/E ÷ 5yr Forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Market cap
Market cap
1,323 Cr
PE
PE
21.87
Prom Holding
Prom Holding
64.09 %
ROE (%)
ROE (%)
17.67
ROCE (%)
ROCE (%)
24.15
Div Yield (%)
Div Yield (%)
0.83
Sales
Sales
510 Cr
OPM (%)
OPM (%)
17.55 %
Debt to Equity
Debt to Equity
0.27
Institutions
Institutions
0.17 %
Individual < 2 lac
Individual < 2 lac
19.26 %
No. of Shareholders
No. of Shareholders
14,131

About

DIL Ltd operates through its subsidiaries like RSIL, FBL, WSEL, and Joint Venture in the Czech… Read more
Low
256
52W Range
High
580
  • Fermenta Biotech
  • Advanced Enzyme Tech
  • Concord Biotech
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Vitamins

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Fermenta Biotech Ltd. Business

    DIL Ltd offers research support services, manufactures enzymes and chemicals, provides entertainment, and develops levitation technology and wheelchairs. They excel in tailored solutions for efficient drug discovery, also involved in property, treasury & other activities.

    Fermenta Biotech major competitors are Advanced Enzyme Tech, Concord Biotech, Biocon, Syncom Formulations, Lincoln Pharma, Jagsonpal Pharma, Bharat Parenterals.
    Market Cap of Fermenta Biotech is ₹1,353 Crs.
    While the median market cap of its peers are ₹1,513 Crs.

    Fermenta Biotech seems to be less financially stable compared to its competitors.
    Altman Z score of Fermenta Biotech is 5.84 and is ranked 6 out of its 8 competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material